Recall Register

Device recall: Mindray BeneVision Distributed Monitoring System (DMS), Part No. 115-034413-00

Class II FDA enforcement event 81084. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

The firm has identified performance anomalies with the device caused when more than 64 TD60 telemetry transmitters have been connected to a central station. The anomaly causes some ECG waveforms to appear as a flat line at the centralized viewing station and will manifest if more than 64 TD60 transmitters have been connected to a given central station server. Each central station supports only…

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Mindray DS USA, Inc. dba Mindray North America started this device recall on 30 Aug 2018. The firm address in the FDA record is in Mahwah, NJ. FDA put the recall in Class II. FDA event 81084 has 1 product record. The first FDA enforcement report date is 24 Oct 2018. The record gives the status Terminated, with the termination date 20 Dec 2018. 362 of the 1,074 device events that started in 2018 have more product records. The median device event of 2018 has 1 product record. The openFDA file has 1,074 device events that started in 2018 and 1,091 that started in 2017.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Distributed to accounts in CA, CO, FL, MA, NY, PA, PR, TX, and WV.

Recalling firm

Mindray DS USA, Inc. dba Mindray North America, Mahwah, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 81084: product records
Recall numberProductQuantityClassStatusReport date
Z-0170-2019Mindray BeneVision Distributed Monitoring System (DMS), Part No. 115-034413-005Class IITerminated24 Oct 2018

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2018
1,074
Share of these events in Class II
92%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
29

Other events of the firm

Other FDA enforcement events of Mindray DS USA, Inc. dba Mindray North America
InitiatedProduct (first record)TypeClassRecords
18 Nov 2025Hardware configuration of the BeneVision Central Monitoring System (CMS), marketed as BeneVision Distributed Monitoring DeviceClass II1
20 Oct 2025Sevoflurane (SEVO) V90 Electronic Vaporizer with the A9 Anesthesia System. Labeled as the following: 1. Sev E_Vap. (SafeDeviceClass II2
15 Aug 2025BeneVision N1 Patient Monitor (N1). Part Numbers: 6660E-PA00017, 6660E-PA00014, 6660E-PA00012, 6660E-PA00011, 6660E-PA00DeviceClass II1
22 Jul 2024Sevoflurane E_Vap.(Quik-Fil):used with the A9 Anesthesia System-Used to provide the vapor of an anesthetic agent with coDeviceClass II4
27 May 20213AA battery cradle (Part Number 045-001699-01) used with BeneVision TD60 Telepack (Model Number 115-047566-00 /115-06004DeviceClass III1
22 Feb 2021Mindray BeneVision Distributed Monitoring System( DMS) 1. p/n 115-051209-00 2. p/n 115-034414-00 and 115-034413-00 when DeviceClass II1
13 Jan 2020DP-30 Digital Ultrasonic Diagnostic Imaging System, Part No. 1155E-PA00004 - Product Usage: The Digital Ultrasonic DiagnDeviceClass II1
9 Dec 2019BA-800M Chemistry Analyzer Part Numbers BA81E-PA00002 and BA81E-PA00003, Containing Gas spring YQ-8/18-90-272-180N (MateDeviceClass II2
1 Oct 2019Accutorr 3 Vital Signs Monitor with NIBP valve assembly board, p/n 115-017679-00, containing software version 8.1.5 - PrDeviceClass II4
24 Jan 2018Hematology Diluent M-30D used with BC-3200 and BC-3600 Hematology Analyzer; Part Numbers: (1) 105-005405-00 (2 x 5.5L coDeviceClass II2

Mindray DS USA, Inc. dba Mindray North America: all 29 events

Official channels

Cite this page

Recall Register. FDA enforcement event 81084. https://recallregister.com/fda/ii/81084/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Distributed to accounts in CA, CO, FL, MA, NY, PA, PR, TX, and WV.
What quantity of product is in FDA event 81084?
The FDA record gives this quantity: 5
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2018 have the same class?
92% of the 1,074 device events that started in 2018 are in Class II.